Irish High Court permits legal challenge against HSE over drug access delays

A 28-year-old patient has secured judicial review to contest the Health Service Executive's (HSE) alleged unreasonable delay in providing access to a life-altering neurological medication. The case highlights ongoing tensions between patient access to orphan drugs and state health budget constraints, with the court's ruling setting a precedent for future administrative challenges.